comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 20:32:03 - browse：5

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Behind warning on Apellis’s eye drug lies a conflict of interest

entertainment

WSS

Ending health disparities requires full federal government, panel says

An outrageous hospital charge: I paid $710 for an hour of babysitting

HCA sued by state AG for quality issues at Mission Health

'The boss' wants server deleted: New allegations emerge in Trump indictment

HCA sued by state AG for quality issues at Mission Health

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

entertainment

comprehensive

explore

BioMarin wins approval for gene therapy to treat hemophilia A

Biden to sign 'historic' executive order on how US military handles sexual assault cases

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How to keep neuroscience’s past racism from being its future

Cancer drug shortages should be causing more outrage

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Activists slam private health insurers over coverage restrictions

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

explore

Hospitals, health systems can help patients avoid medical debt

Biden announces an advanced cancer research initiative

Three trends to watch in biotech in 2024

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Carvykti CAR

Carvykti CAR

leisure time

entertainment

hotspot

hotspot